These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21190401)

  • 1. A review of computer-based interventions used in the assessment, treatment, and research of drug addiction.
    Bickel WK; Christensen DR; Marsch LA
    Subst Use Misuse; 2011; 46(1):4-9. PubMed ID: 21190401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of presentations to a community-based specialist addiction neuropsychology service: Cognitive profiles, diagnoses and comorbidities.
    Gooden JR; Cox CA; Petersen V; Curtis A; Manning V; Lubman DI
    Drug Alcohol Rev; 2021 Jan; 40(1):83-92. PubMed ID: 32789930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating primary medical care with addiction treatment: a randomized controlled trial.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Lu Y
    JAMA; 2001 Oct; 286(14):1715-23. PubMed ID: 11594896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of technology-assisted self-help and minimal contact therapies for drug and alcohol abuse and smoking addiction: is human contact necessary for therapeutic efficacy?
    Newman MG; Szkodny LE; Llera SJ; Przeworski A
    Clin Psychol Rev; 2011 Feb; 31(1):178-86. PubMed ID: 21095051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the dollar value of health outcomes from drug-abuse interventions.
    French MT; Mauskopf JA; Teague JL; Roland EJ
    Med Care; 1996 Sep; 34(9):890-910. PubMed ID: 8792779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings.
    McCollister KE; French MT
    Addiction; 2003 Dec; 98(12):1647-59. PubMed ID: 14651494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and effectiveness of substance abuse treatments for homeless persons.
    Schumacher JE; Mennemeyer ST; Milby JB; Wallace D; Nolan K
    J Ment Health Policy Econ; 2002 Mar; 5(1):33-42. PubMed ID: 12529568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology-based interventions targeting substance use disorders and related issues: an editorial.
    Marsch LA
    Subst Use Misuse; 2011; 46(1):1-3. PubMed ID: 21190400
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness of addiction care].
    Suijkerbuijk AW; van Gils PF; Greeven PG; de Wit GA
    Tijdschr Psychiatr; 2015; 57(7):498-507. PubMed ID: 26189418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.
    Mojtabai R; Zivin JG
    Health Serv Res; 2003 Feb; 38(1 Pt 1):233-59. PubMed ID: 12650390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A research agenda for economic evaluation of substance abuse services.
    French MT; Drummond M
    J Subst Abuse Treat; 2005 Sep; 29(2):125-37. PubMed ID: 16135341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social pressure, coercion, and client engagement at treatment entry: a self-determination theory perspective.
    Wild TC; Cunningham JA; Ryan RM
    Addict Behav; 2006 Oct; 31(10):1858-72. PubMed ID: 16480834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the physician in addiction prevention and treatment.
    Miller NS; Sheppard LM
    Psychiatr Clin North Am; 1999 Jun; 22(2):489-505. PubMed ID: 10385946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of substance abuse treatment.
    Barnett PG
    Curr Psychiatry Rep; 1999 Dec; 1(2):166-71. PubMed ID: 11122920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI.
    French MT; Salomé HJ; Sindelar JL; McLellan AT
    Health Serv Res; 2002 Apr; 37(2):433-55. PubMed ID: 12036002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does treatment 'pay for itself'? Looking at the economic argument for addiction treatment.
    Ettner SL
    Behav Healthc; 2006 May; 26(5):32-4. PubMed ID: 16736917
    [No Abstract]   [Full Text] [Related]  

  • 20. Youth social behaviour and network therapy (Y-SBNT): adaptation of a family and social network intervention for young people who misuse alcohol and drugs - a randomised controlled feasibility trial.
    Watson J; Toner P; Day E; Back D; Brady LM; Fairhurst C; Renwick C; Templeton L; Akhtar S; Lloyd C; Li J; Cocks K; Ambegaokar S; Parrott S; McArdle P; Gilvarry E; Copello A
    Health Technol Assess; 2017 Mar; 21(15):1-260. PubMed ID: 28399988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.